CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
57 hedge funds and large institutions have $23.4M invested in CTI BioPharma Corp. (DE) Common Stock in 2019 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 19 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
58% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 19
Holders
57
Holding in Top 10
–
Calls
$169K
Puts
$61K
Top Buyers
| 1 | +$637K | |
| 2 | +$350K | |
| 3 | +$290K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$212K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$192K |
Top Sellers
| 1 | -$2.27M | |
| 2 | -$868K | |
| 3 | -$414K | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$212K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$161K |